Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

NCT02470299 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: Ketorolac
OTHER: Placebo

Sponsor

New Mexico Cancer Research Alliance